GW&K Investment Management, LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
GW&K Investment Management, LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$10,192,000
+104.0%
295,848
-1.1%
0.13%
+90.0%
Q2 2020$4,996,000
+14.1%
298,996
-1.5%
0.07%
-9.1%
Q1 2020$4,378,000
-50.7%
303,581
+14.4%
0.08%
-35.3%
Q4 2019$8,883,000
+53.1%
265,402
-4.2%
0.12%
+45.1%
Q3 2019$5,802,000
+41.7%
277,064
+40.9%
0.08%
+32.3%
Q2 2019$4,094,000
-7.8%
196,618
-1.0%
0.06%
-13.9%
Q1 2019$4,441,000
-18.9%
198,692
-13.2%
0.07%
-33.3%
Q4 2018$5,473,000
+7.8%
228,820
+22.9%
0.11%
+31.7%
Q3 2018$5,079,000186,1930.08%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders